X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Wockhardt Fact Sheet, Wockhardt Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Wockhardt Fact Sheet   (WOCK)

Here is the latest financial fact sheet of Wockhardt. For more details, see the Wockhardt quarterly results and Wockhardt share price and chart. For a sector overview, read our pharmaceuticals sector report.

WOCKHARDT LTD. Price History

Price Rs 609.3
Mkt Cap Rs m 67,042
Vol '000 286.2
P/E X 18.4
P/CF X 14.1
EPS (TTM) Rs 33.1
% ch % 3.7
No. of shares m 110.04
% ch week % 5.2
% ch 1-mth % 0.8
% ch 12-mth % -33.0
52 week H/L Rs 1,129.0/555.0
(As on Jun 29, 2017 03:36:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

WOCKHARDT LTD. Financials

No. of Mths
Year Ending
12
Mar-12
*
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
WOCKHARDT LTD. EQUITY SHARE DATA
High Rs6222,1662,0701,9802,000 
Low Rs251598337455706 
Sales per share (Unadj.) Rs397.5511.9440.1407.2403.7 
Earnings per share (Unadj.) Rs31.3145.576.636.829.5 
Diluted earnings per shareRs31.1144.976.436.829.6 
Cash flow per share (Unadj.) Rs41.8156.689.450.042.4 
Dividends per share (Unadj.) Rs05.0010.0020.000 
Adj. dividends per shareRs0.004.989.9720.010.00 
Dividend yield (eoy) %00.40.81.60 
Book value per share (Unadj.) Rs64.8219.5299.1310.4323.4 
Adj. book value per shareRs64.5218.6298.3310.5324.8 
Shares outstanding (eoy) m109.44109.58109.75110.07110.51 
Bonus/Rights/Conversions  -ESOPESOPESOP- 
Price / Sales ratio x1.12.72.73.03.4 
Avg P/E ratio x13.99.515.733.145.9 
P/CF ratio (eoy) x10.48.813.524.331.9 
Price / Book Value ratio x6.76.34.03.94.2 
Dividend payout %03.413.154.40 
Avg Mkt Cap Rs m47,771151,429132,062133,983149,509 
No. of employees `0007.9NA8.66.87.4 
Total wages/salary Rs m5,7296,5597,6868,6899,443 
Avg. sales/employee Rs Th5,507.0NM5,616.76,557.76,048.6 
Avg. wages/employee Rs Th725.2NM893.81,271.41,280.2 
Avg. net profit/employee Rs Th433.8NM977.6592.5441.5 
WOCKHARDT LTD. INCOME DATA
Net Sales Rs m43,50556,09448,30444,81544,614 
Other income Rs m233512384666970 
Total revenues Rs m43,73856,60648,68845,48145,584 
Gross profit Rs m13,55720,62510,2577,0945,038 
Depreciation Rs m1,1511,2211,3991,4541,426 
Interest Rs m2,6902,1548345521,012 
Profit before tax Rs m9,95017,7628,4085,7533,570 
Minority Interest Rs m00-21-78-65 
Prior Period Items Rs m11-6006 
Extraordinary Inc (Exp) Rs m-4,31676749800 
Tax Rs m2,2172,5824791,627255 
Profit after tax Rs m3,42715,9418,4074,0493,257 
Gross profit margin %31.236.821.215.811.3 
Effective tax rate %22.314.55.728.37.1 
Net profit margin %7.928.417.49.07.3 
WOCKHARDT LTD. BALANCE SHEET DATA
Current assets Rs m24,81533,26933,55935,21639,906 
Current liabilities Rs m18,90917,73517,43217,73018,423 
Net working cap to sales %13.627.733.439.048.2 
Current ratio x1.31.91.92.02.2 
Inventory Days Days7569758390 
Debtors Days Days6462366098 
Net fixed assets Rs m34,73624,80530,02231,30035,832 
Share capital Rs m547548549550553 
"Free" reserves Rs m6,14121,53128,21929,97730,370 
Net worth Rs m7,09724,05632,82934,16835,739 
Long term debt Rs m27,06414,75211,02311,84816,542 
Total assets Rs m62,53860,22766,22069,38979,522 
Interest coverage x4.79.211.111.44.5 
Debt to equity ratio x3.80.60.30.30.5 
Sales to assets ratio x0.70.90.70.60.6 
Return on assets %9.830.014.06.65.4 
Return on equity %48.366.325.611.99.1 
Return on capital %24.453.322.213.58.7 
Exports to sales %27.820.912.810.011.6 
Imports to sales %6.75.17.86.24.5 
Exports (fob) Rs m12,09411,7406,1804,4715,177 
Imports (cif) Rs m2,8992,8433,7602,7731,990 
Fx inflow Rs m13,78914,58211,02610,7407,589 
Fx outflow Rs m4,0403,6244,3613,3562,878 
Net fx Rs m9,74910,9596,6657,3834,711 
WOCKHARDT LTD. CASH FLOW
From Operations Rs m 13,438 15,324 14,763 3,550 716 
From Investments Rs m -3,055 10,854 -8,516 -2,066 -8,182 
From Financial Activity Rs m -8,266 -22,458 -6,013 -757 2,543 
Net Cashflow Rs m 2,118 3,720 234 727 -4,923 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 74.5%
Foreign collaborators 0.0%
Indian inst/Mut Fund 2.3%
FIIs 7.7%
ADR/GDR 0.1%
Free float 15.4%
Shareholders 67,757
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Wockhardt Towers, C/2-G Block, BKC, Bandra (E), Mumbai-400 051
E-MAIL investorrelations@wockhardt.com WEB www.wockhardt.com
TELEPHONE (022) 2653 4444 FAX (022) 2652 3905
SECTOR PHARMACEUTICALS GROUP KHORAKIWALA
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR Haribhakti & Co.
CHM: Habil Khorakiwala COMP SEC: V. R. Khetan YEAR OF INC: 1973 BSE CODE: 532300 FV (Rs): 5 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   NOVARTIS  KERALA AYURV  ELDER PHARMA  PLETHICO PHARMA  J.B.CHEMICALS  

Compare WOCKHARDT LTD. With:   NOVARTIS  KERALA AYURV  ELDER PHARMA  PLETHICO PHARMA  J.B.CHEMICALS  

Compare WOCKHARDT LTD. With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trims Early Gains to Finish Flat; Indigo Slips 2.3%(Closing)

Indian share markets trimmed its early gains in the afternoon session to finish just above the dotted line amid mixed global cues.

Views on news

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

More Views on News

Most Popular

The 'Multibagger IPOs' You Should Be Betting On(The 5 Minute Wrapup)

Jun 22, 2017

Multibagger IPOs are few and far between. Here's how to spot them...

After Farm Loans, Will Govts Waive Off Mudra Loans Next?(Vivek Kaul's Diary)

Jun 19, 2017

If borrowers organise themselves and ask the government to waive off their loans, the government will find it very difficult to say no, having already established a precedent.

Get Ready for Commodity Options!(Daily Profit Hunter)

Jun 16, 2017

Commodity options trading is one step closer to reality. Learn how to take advantage of this tremendous opportunity.

Walter Schloss' Investing Record(Chart Of The Day)

Jun 17, 2017

In a market full of one-hit-wonders, this investor obviously had a formula that worked. And through the think-and-thin of the market.

11 Hidden Costs Associated With Your Home Loan(Outside View)

Jun 16, 2017

Various costs associated with a home loan.

More

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 8-QTR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS